Tiger Woods Hospitalized After Wreck in Los Angeles

News

Professional golfer Tiger Woods has multiple injuries to his legs after a Tuesday morning one-vehicle wreck in Los Angeles, his agent, Mark Steinberg, told Golf Digest.



Tiger Woods AP

“He is currently in surgery,” Steinberg said, “and we thank you for your privacy and support.”

Woods, 45, was the only occupant of a vehicle involved in a roll-over accident about 7:15 a.m. PT Tuesday on the border of Rolling Hills Estates and Rancho Palos Verdes, the Los Angeles County Sheriff’s Office said on Twitter. He was extracted from the vehicle with the “jaws of life,” the sheriff’s office said.

He was taken to Harbor UCLA Medical Center. The vehicle sustained major damage. Authorities did not say what caused the wreck.

CNN, citing Los Angeles County spokesperson Henry Narvaez, reported that Woods suffered moderate to critical injuries.

Woods, the winner of 15 major PGA tournaments, was in California for a 2-day shoot with Golf Digest/GOLFTV. Over the weekend, he’d served as a host for the PGA Tour’s Genesis Invitational over the weekend, Golf Digest said.

Woods last competed in the PNC Championship in Orlando with his son on Dec. 20 said. He announced last month that he underwent back surgery to remove a pressurized disc fragment and hoped to be ready to play in The Masters tournament in early April.

Sources

Golf Digest. “Tiger Woods suffers multiple leg injuries in single-car accident in Los Angeles”

https://www.golfdigest.com/story/tiger-woods-car-accident-los-angeles

Twitter

CNN. “Tiger Woods in surgery with ‘multiple leg injuries’ after rollover car accident near LA, agent says”

https://www.cnn.com/2021/02/23/us/tiger-woods-car-accident-intl-spt/index.html

Products You May Like

Articles You May Like

Proportion of children in Medicaid managed care plans increases from 65% to 94%
Marlboro maker Altria asks FDA to spread the word that nicotine doesn’t cause cancer
Maternal diet may enhance immune systems of premature infants, study shows
Tezepelumab is the First Biologic to Consistently and Significantly Reduce Exacerbations in Broad Population of Severe Asthma Patients
Regeneron Announces Positive Phase 2 Data Evaluating Fel d 1 Antibody Cocktail in Cat-allergic Patients with Mild Asthma

Leave a Reply

Your email address will not be published. Required fields are marked *